NIH-funded research NIH-funded research

Biocompatible coating to improve aneurysm devices

Official title: Development of a novel biocompatible polymer coating for aneurysm treatment devices

Funded at Aneuvas Technologies, INC. · NIH-11316546 · Data updated 2026-11-12

A new biocompatible polymer coating for aneurysm treatment devices is being developed to reduce clotting and improve healing without heavy drug therapy.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionAneuvas Technologies, INC.
NIH-funded
Lab location1 site (Flagstaff, UNITED STATES)
Project startSeptember 4, 2026
Project endAugust 31, 2028
Funding year2026
Award (this year)$435,979
NIH project number1R41NS143513-01A1
Project IDNIH-11316546 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are adults with intracranial aneurysms who are treated with endovascular devices and are eligible for device coatings.

Less likely to help

Patients not receiving endovascular aneurysm treatment or those with contraindications to device implants may not benefit.

What this research studies

This project aims to coat nitinol-based aneurysm devices with a polymer material that is safer and more compatible with the body. The team will refine coating methods to ensure durable, non-thrombogenic surfaces that support tissue regrowth. By focusing on surface modifications and nano-scale treatments, they hope to improve endothelial healing and reduce recurrence after device placement. The work builds on prior findings about PPODA-QT coatings and intends to apply them to flow diverters used in patients with brain aneurysms.

Why it matters

Potential benefit: If successful, patients could experience safer aneurysm treatment with fewer blood-thinning medications and lower risk of device-related complications.

How similar studies have gone: Previous studies showed promising biocompatible coatings, but this project extends coating to nitinol flow diverters and human-use devices.

Where this research is happening

  • Aneuvas Technologies, INC.
    Flagstaff, United States
    Active

Researchers

  • Principal investigator: Becker, Timothy Andrew — Aneuvas Technologies, INC.
  • Study coordinator: Becker, Timothy Andrew

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.